ONCY:NASDAQ
Oncolytics Biotech Inc
$0.50
arrow_upward
+0.42%(+0.0021) 1D
$0.49
arrow_downward
-1.99% (-0.010)bedtimeAfter hours
Closed: Oct 23, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.50
High
$0.51
Low
$0.49
Mkt. cap
65.86M
Avg. vol.
1.29M
Volume
376.01K
52-wk high
$1.32
52-wk low
$0.44
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.50
High
$0.51
Low
$0.49
Mkt. cap
65.86M
Avg. vol.
1.29M
Volume
376.01K
52-wk high
$1.32
52-wk low
$0.44
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
Investor's Business Daily
·
10 hours ago
What To Do In A Doom-And-Bloom Market; 3 Titans Loom
AOL.com
·
5 hours ago
The Nasdaq Just Had Its Worst Day in 4 Months. Here's the Level That Would Signal a Correction, and What History Says Investors Can Do About It.
Yahoo Finance
·
4 hours ago
Before You Buy the Vanguard S&P 500 ETF, There's 1 Sneaky Risk Investors Should Know
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com